NVL-655 Is a Selective and Brain-Penetrant Inhibitor of Diverse ALK Mutant Oncoproteins, Including Lorlatinib-Resistant Compound Mutations
Lin, J.J., Horan, J.C., Tangpeerachaikul, A., Swalduz, A., Valdivia, A., Johnson, M., Besse, B., Camidge, D.R., Fujino, T., Yoda, S., Nguyen-Phuong, L., Mizuta, H., Bigot, L., Nobre, C., Lee, J.B., Yu, M.R., Mente, S., Sun, Y., Kohl, N.E., Porter, J.R., Shair, M.D., Zhu, V.W., Felip, E., Cho, B.C., Friboulet, L., Hata, A.N., Pelish, H.E., Drilon, A.To be published.